PMID- 28938929
OWN - NLM
STAT- MEDLINE
DCOM- 20180525
LR  - 20180525
IS  - 1549-4713 (Electronic)
IS  - 0161-6420 (Linking)
VI  - 124
IP  - 10
DP  - 2017 Oct
TI  - Bullseye Retinopathy from Antiretroviral Therapy.
PG  - 1539
LID - S0161-6420(17)30911-9 [pii]
LID - 10.1016/j.ophtha.2017.04.001 [doi]
FAU - Abalem, Maria Fernanda
AU  - Abalem MF
AD  - Department of Ophthalmology, Faculty of Medicine, University of Sao Paulo,
      Brazil; W.K. Kellogg Eye Center, Department of Ophthalmology & Visual Sciences,
      University of Michigan, Ann Arbor, Michigan.
FAU - Carricondo, Pedro Carlos
AU  - Carricondo PC
AD  - Department of Ophthalmology, Faculty of Medicine, University of Sao Paulo,
      Brazil.
FAU - Rao, Rajesh C
AU  - Rao RC
AD  - W.K. Kellogg Eye Center, Department of Ophthalmology & Visual Sciences,
      University of Michigan, Ann Arbor, Michigan.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Ophthalmology
JT  - Ophthalmology
JID - 7802443
RN  - 0 (Anti-HIV Agents)
RN  - 0 (Benzoxazines)
RN  - 0 (Reverse Transcriptase Inhibitors)
RN  - 2T8Q726O95 (Lamivudine)
RN  - 4B9XT59T7S (Zidovudine)
RN  - JE6H2O27P8 (efavirenz)
SB  - IM
MH  - Anti-HIV Agents/*adverse effects
MH  - Benzoxazines/*adverse effects
MH  - Humans
MH  - Lamivudine/*adverse effects
MH  - Male
MH  - Middle Aged
MH  - Retinal Diseases/*chemically induced
MH  - Reverse Transcriptase Inhibitors/adverse effects
MH  - Zidovudine/*adverse effects
EDAT- 2017/09/25 06:00
MHDA- 2018/05/26 06:00
CRDT- 2017/09/24 06:00
PHST- 2017/03/22 00:00 [received]
PHST- 2017/04/02 00:00 [revised]
PHST- 2017/04/03 00:00 [accepted]
PHST- 2017/09/24 06:00 [entrez]
PHST- 2017/09/25 06:00 [pubmed]
PHST- 2018/05/26 06:00 [medline]
AID - S0161-6420(17)30911-9 [pii]
AID - 10.1016/j.ophtha.2017.04.001 [doi]
PST - ppublish
SO  - Ophthalmology. 2017 Oct;124(10):1539. doi: 10.1016/j.ophtha.2017.04.001.